injectable l-carnitine dosage for weight loss Injections: A Clinical Guide Practitioners Where to Inject L-Carnitine for

rhamnosus GR-1 and L

Key finding: Most common AE: mild injection site erythema (12%)

4,12 End-of-dose failure and the "wearing off" phenomenon: In elderly persons, 30% of hospital admissions may be linked to drug-related problems, and falls leading to hospitalizations are especially likely in patients with PD, particularly those experiencing "wearing off," a loss of benefit from a dose of L-dopa that typically occurs after a few hours

Carnitine deficiency results in an inability to utilise fatty acids as an energy source, and causes skeletal muscle dysfunction and weakness, heart enlargement, heart failure and rhythm distrubances and liver dysfuction